AC
IMPV

Ascend Capital’s Imperva, Inc. IMPV Stock Holding History

Ascend Capital’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$4.92M Sell
105,998
-8,301
-7% -$402K 0.25% 100
2018
Q2 		$5.51M Buy
+114,299
New +$5.47M 0.26% 103

Other funds holding IMPV

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ascend Capital's IMPV Position: Q3 2018 in Review

Ascend Capital reduced its Imperva, Inc. (IMPV) stake by 7.3% in Q3 2018, selling an estimated $402K and leaving 105,998 shares worth $4.92M. The position accounts for 0.25% of the portfolio, ranked #100.

Ascend Capital first reported a position in IMPV in Q2 2018 and has held it in 2 quarters since. The position peaked at $5.51M in Q2 2018. 168 funds tracked by Wall St. Rank hold IMPV as of Q3 2018.

  • Ascend Capital held 105,998 shares of Imperva, Inc. worth $4.92M as of Q3 2018.
  • Ascend Capital sold 8,301 Imperva, Inc. shares in Q3 2018, an estimated $402K.
  • Imperva, Inc. made up 0.25% of Ascend Capital's portfolio in Q3 2018, its #100 holding.
  • Ascend Capital first reported a position in Imperva, Inc. in Q2 2018 and has held it in 2 quarters since.
  • Ascend Capital's Imperva, Inc. position peaked at $5.51M in Q2 2018.
  • 168 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.